Skip to Main Content

Paper Details

Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Bioinformatics
8
2022
Cancer, cancer, cancer cells, cancer driver genes, cancer genomes, genomes, oncogenic, patients, tumor, tumor genome
Author NameAffiliation
Francisco Mart??nez-Jim??nezInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology
Alfonso ValenciaJosep Carreras Leukaemia Research Institute (IJC)
Alfonso ValenciaInstitucio Catalana de Recerca i Estudis Avancats (ICREA)
Alfonso ValenciaJosep Carreras Leukaemia Research Institute (IJC)
Alfonso ValenciaInstitucio Catalana de Recerca i Estudis Avancats (ICREA)
Eduard Porta-PardoJosep Carreras Leukaemia Research Institute (IJC)
Eduard Porta-Pardo
  • 1 - 7

Datasets

Release 1.2